<!DOCTYPE html>
<html lang="en">

<head>
  <title>Seizure Disorders (Incomplete) | The Peripheral Brain</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <script src='https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.2/MathJax.js?config=TeX-MML-AM_CHTML'></script>

  <link rel="stylesheet" href="/peripheral_brain/css/main.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/mobile.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/buttons.css" />

  
    <link rel="stylesheet" href="/peripheral_brain/css/diseases.css">
  


  <link href="https://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Slab" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Mono" rel="stylesheet">


  <link rel="apple-touch-icon" sizes="57x57" href="/peripheral_brain/favicons/apple-icon-57x57.png">
  <link rel="apple-touch-icon" sizes="60x60" href="/peripheral_brain/favicons/apple-icon-60x60.png">
  <link rel="apple-touch-icon" sizes="72x72" href="/peripheral_brain/favicons/apple-icon-72x72.png">
  <link rel="apple-touch-icon" sizes="76x76" href="/peripheral_brain/favicons/apple-icon-76x76.png">
  <link rel="apple-touch-icon" sizes="114x114" href="/peripheral_brain/favicons/apple-icon-114x114.png">
  <link rel="apple-touch-icon" sizes="120x120" href="/peripheral_brain/favicons/apple-icon-120x120.png">
  <link rel="apple-touch-icon" sizes="144x144" href="/peripheral_brain/favicons/apple-icon-144x144.png">
  <link rel="apple-touch-icon" sizes="152x152" href="/peripheral_brain/favicons/apple-icon-152x152.png">
  <link rel="apple-touch-icon" sizes="180x180" href="/peripheral_brain/favicons/apple-icon-180x180.png">
  <link rel="icon" type="image/png" sizes="192x192"  href="/peripheral_brain/favicons/android-icon-192x192.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/peripheral_brain/favicons/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="96x96" href="/peripheral_brain/favicons/favicon-96x96.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/peripheral_brain/favicons/favicon-16x16.png">
  <link rel="manifest" href="/peripheral_brain/favicons/manifest.json">
  <meta name="msapplication-TileColor" content="#748cab">
  <meta name="msapplication-TileImage" content="/peripheral_brain/favicons/ms-icon-144x144.png">
  <meta name="theme-color" content="#748cab">
</head>


<body class="body">
<header>
  <nav>
    <!-- <a href="/peripheral_brain/home.html"><img src="/peripheral_brain/images/logo_1000x1000.png" alt="Logo"> -->
      <ul class="nav-links">
        <li><a href="/peripheral_brain/home.html">Home</a></li>
        <li><a href="/peripheral_brain/disease_list.html">Diseases and Drugs</a></li>
        <li><a href="/peripheral_brain/lab_values">Lab Values</a></li>
        <li><a href="/peripheral_brain/formulas">Formulas</a></li>
        <li><a href="/peripheral_brain/calculators.html">Calculators</a></li>
      </ul>
  </nav>
</header>


<h1 class="title">Seizure Disorders (Incomplete)</h1>

<div class="contents">

  <div class="toc">
    
      <ul>
  <li><a href="#seizure-classification">Seizure Classification</a>
    <ul>
      <li><a href="#focal-szs">Focal Szs</a></li>
      <li><a href="#generalized-szs">Generalized Szs</a></li>
      <li><a href="#post-ictal-states">Post-Ictal States</a>
        <ul>
          <li><a href="#ssx">SSx</a></li>
        </ul>
      </li>
    </ul>
  </li>
  <li><a href="#seizure-pathophysiology">Seizure Pathophysiology</a></li>
  <li><a href="#status-epilepticus-managment">Status Epilepticus Managment</a>
    <ul>
      <li><a href="#common-triggers">Common Triggers</a></li>
      <li><a href="#drug-triggers">Drug Triggers</a></li>
      <li><a href="#management-of-status-epilepticus">Management of Status Epilepticus</a></li>
    </ul>
  </li>
  <li><a href="#seizure-management">Seizure Management</a>
    <ul>
      <li><a href="#criteria-for-considering-dc-of-aed">Criteria for Considering D/C of AED</a></li>
      <li><a href="#medication-therapy">Medication Therapy</a>
        <ul>
          <li><a href="#phenytoin--fosphenytoin">Phenytoin / Fosphenytoin</a></li>
        </ul>
      </li>
      <li><a href="#valproate">Valproate</a></li>
    </ul>
  </li>
</ul>

    
  </div>

  <div class="content">
    <h1 id="seizure-classification">Seizure Classification</h1>

<h2 id="focal-szs">Focal Szs</h2>

<p>Focal Szs are classified as either preserved (simple partial) or altered (complex partial) awareness. Simple Szs can degenerate into complex, and either can evolve into bilateral, generalized, tonic-clonic szs.</p>

<ul>
  <li>Aware Partial Szs
    <ul>
      <li>Limited Convulsions, No LOC, and Limited Sensory Disturbances</li>
      <li>May Present w/ auras of abdominal discomfort, unpleasant smells, or a sense of fear</li>
    </ul>
  </li>
  <li>Impaired Awareness Partial Szs
    <ul>
      <li>Present w/ clouding of consciousness, staring, and repetitive motor behaviors</li>
      <li>May also present with autonomic dysfunction (diarrhea, vomiting, etc)</li>
      <li>Auras are common (same SSx as Aware Partial Szs)</li>
      <li>Most common form of focal Sz</li>
    </ul>
  </li>
</ul>

<h2 id="generalized-szs">Generalized Szs</h2>

<p>Generalized Szs can be classified as the following</p>

<ul>
  <li>Absence
    <ul>
      <li>No Convulsions, Aura, or Post-Ictal Period</li>
      <li>Typical (Petit-Mal Szs): Brief LOC (10-45s) w/ staring or eye flickering, often repetitive</li>
      <li>Atypical: Slower onset than Petit-Mal and more difficult to control</li>
    </ul>
  </li>
  <li>Myoclonic
    <ul>
      <li>Shock-Like Muscle Contractions</li>
      <li>Isolated location jerking (head, trunk, etc)</li>
    </ul>
  </li>
  <li>Tonic
    <ul>
      <li>Often occur in children</li>
      <li>Increased rigidity of extensor muscles</li>
    </ul>
  </li>
  <li>Clonic
    <ul>
      <li>Often occur in children</li>
      <li>Rapid, repetitive motor activity</li>
    </ul>
  </li>
  <li>Tonic-Clonic (Grand-Mal)
    <ul>
      <li>Cyclical tonic phase (15-30s of muscle rigidity) followed by clonic phase (1-2min of violent jerking)</li>
      <li>Tremor begins to develop in tonic phase as clonic phase begins</li>
      <li>Commonly presents w/ urinary incontinence</li>
      <li>Characteristic of Epilepsy</li>
    </ul>
  </li>
  <li>Atonic
    <ul>
      <li>Sudden loss of muscle tone</li>
    </ul>
  </li>
  <li>Status Epilepticus
    <ul>
      <li>Single Sz or Multiple Szs w/o baseline consciousness for â‰¥ 30min</li>
      <li>Usually begin treatment after &gt; 5min</li>
    </ul>
  </li>
</ul>

<h2 id="post-ictal-states">Post-Ictal States</h2>

<p>Post-Ictal states can last from seconds to hours, and depending upon the length of the Sz, age of the patient, use of anti-epileptic drugs (AEDs), and areas of the brain that are affected.</p>

<h3 id="ssx">SSx</h3>

<ul>
  <li>Confusion</li>
  <li>Disorientation</li>
  <li>Anterograde Amnesia</li>
</ul>

<h1 id="seizure-pathophysiology">Seizure Pathophysiology</h1>

<p>An imbalance in Excitatory and Inhibitory Post-Synaptic Potentials leads to the development of a Sz. Excitatory potentials are often caused by AMPA and NMDA receptors (glutamate receptors) leading to Ca influx and depolarization. Hyperpolarization is often mediated by GABA receptors leading to K efflux through both voltage gated and Ca defendant K efflux channels. Tonic phases of Szs are often carried out by loss of GABA mediated inhibition leading to excessive activation by glutamate, and clonic phases/oscillations occur due to the reintroduction of GABA mediation.</p>

<h1 id="status-epilepticus-managment">Status Epilepticus Managment</h1>

<h2 id="common-triggers">Common Triggers</h2>

<ul>
  <li>Prenatal Injury</li>
  <li>Hemorrhage</li>
  <li>Infection</li>
  <li>Trauma</li>
  <li>Tumors</li>
  <li>Cerebrovascular Disease</li>
  <li>Anoxia</li>
  <li>Hyperventillation / Respiratory Alkalosis</li>
  <li>Hypoglycemia</li>
  <li>Sleep Deprivation</li>
  <li>Stress</li>
  <li>DTs</li>
  <li>AED Withdrawal</li>
  <li>Repetitive Light Stimulation</li>
</ul>

<h2 id="drug-triggers">Drug Triggers</h2>

<ul>
  <li>EtOH</li>
  <li>Burpropion</li>
  <li>Theophylline</li>
  <li>Imipenem</li>
  <li>Phenothiazines</li>
  <li>Oral Contraceptives</li>
  <li>Tramadol</li>
  <li>Depressant Withdrawal (Esp EtOH and Benzos)</li>
  <li>Meperidine</li>
  <li>CNS Stimulants</li>
  <li>Memantine</li>
  <li>Heave Metal Toxicity</li>
  <li>Clozapine</li>
</ul>

<h2 id="management-of-status-epilepticus">Management of Status Epilepticus</h2>

<ol>
  <li>0-5min
    <ul>
      <li>ABCs</li>
      <li>EEG</li>
      <li>Blood Glucose
        <ul>
          <li>If &lt; 60, give 100mg IV Thiamine and 50mL IV D5W</li>
        </ul>
      </li>
      <li>CBC w/ Diff</li>
      <li>Comprehensive Metabolic Panel (CMP)</li>
      <li>Toxicology Screen</li>
    </ul>
  </li>
  <li>5-20min
    <ul>
      <li>Midazolam IM 10mg if &gt; 40kg or 5mg if 13-40kg (one dose)</li>
      <li>Lorazepam 0.1 mg/kg IV (Max 4 mg/dose) (Max of 2 doses)</li>
      <li>Diazepam 0.15-2 mg/kg IV (Max 10 mg/dose) (Max of 2 doses)</li>
      <li>Phenobarbital 15 mg/kg/dose IV (single dose, <strong>not preferred agent</strong>)</li>
      <li>Diazepam 0.2-0.5 mg/kg Rectal (Max 20 mg/dose) (<strong>not preferred agent</strong>)</li>
      <li>Intranasal Midazolam or Buccal Midazolam (<strong>not preferred agent</strong>)</li>
    </ul>
  </li>
  <li>20-40min
    <ul>
      <li>Fosphenytoin 20 mg PE/kg IV (Max 1500 mg PE/dose, single dose) (PE = Phenytoin Equivalents)</li>
      <li>Valproic Acid 40 mg/kg IV (Max 3000 mg/dose, single dose)</li>
      <li>Levetiracetam 60 mg/kg IV (Max 4500 mg/dose, single dose)</li>
      <li>Phenobarbital 15 mg/kg/dose IV (single dose, <strong>not preferred agent</strong>)</li>
    </ul>
  </li>
  <li>40-60min
    <ul>
      <li>Repeat Second Line Therapy (Step 3) OR</li>
      <li>Anesthetic Doses of the following PLUS Continuous EEG
        <ul>
          <li>Thiopental</li>
          <li>Midazolam</li>
          <li>Phenobarbital</li>
          <li>Propofol</li>
        </ul>
      </li>
    </ul>
  </li>
</ol>

<h1 id="seizure-management">Seizure Management</h1>

<h2 id="criteria-for-considering-dc-of-aed">Criteria for Considering D/C of AED</h2>

<p>2-5yr Sz free period</p>

<p>Risk Factors for recurrence include:</p>

<ul>
  <li>&lt; 2 years seizure free</li>
  <li>Onset of seizure after age 12</li>
  <li>History of atypical febrile seizures</li>
  <li>2-6yr before good seizure control in treatment</li>
  <li>Significant number of seizures (&gt; 30) before control achieved</li>
  <li>
    <p>Partial seizures (which is the most common type)</p>
  </li>
  <li>Abnormal EEG throughout treatment</li>
  <li>Organic neurological disorder
    <ul>
      <li>Traumatic brain injury</li>
      <li>Dementia</li>
    </ul>
  </li>
  <li>Withdrawal of phenytoin or valproate</li>
</ul>

<h2 id="medication-therapy">Medication Therapy</h2>

<h3 id="phenytoin--fosphenytoin">Phenytoin / Fosphenytoin</h3>

<ul>
  <li>Phenytoin: 20 mg/kg IV w/ a second dose after 10min if needed</li>
  <li>Phenytoin: Maximum Infusion Rate of 50 mg/min IV</li>
  <li>Fosphenytoin: 20 PE/kg IV w/ a second dose after 10min if needed</li>
  <li>
    <p>Fosphenytoin: Maximum Infusion Rate of 150 PE/min IV</p>
  </li>
  <li>Phenytoin Limiting SE of Infusion rate is hypotension due to propylene glycol</li>
  <li>Monitor for purple glove syndrome</li>
  <li>Cardiac Monitoring Required</li>
  <li>Oral Dose Conversion
    <ul>
      <li>Adjusted Concentration: <script type="math/tex">\frac{\text{Observed Concentration}}{0.25*\text{Albumin}+0.1}</script></li>
      <li>Albumin and serum concentration must be measured at the same time</li>
    </ul>
  </li>
  <li>Target Concentration: 10-20 mcg/mL</li>
</ul>

<h2 id="valproate">Valproate</h2>

<ul>
  <li>
    <p>Load 15-20 mg/kg</p>
  </li>
  <li>
    <p>Follow with 15 mg/kg QD titrated to Max 60 mg/kg QD</p>

    <ul>
      <li>IV dose given Q6H</li>
    </ul>
  </li>
  <li>
    <p>IV:PO Conversion is 1:1</p>
  </li>
  <li>
    <p>Loading Dose Calculation</p>

    <ul>
      <li>Dose: <script type="math/tex">V_d * ([\text{Desired}]-[\text{Current}]) * Wt</script></li>
      <li>V<sub>d</sub>: 0.2-0.3 L/kg</li>
      <li>Target Concentration: 80 mcg/kg (50-125 mcg/mL)</li>
    </ul>

    <p><strong>PICK UP AT OTHER INPATIENT TREATMENT CONSIDERATIONS SLIDE 14</strong></p>
  </li>
</ul>

  </div>

</div>

<div class="credits">
  <p>Author: Corbin Cox <br>
  Created: 2018-3-19 <br>
  Last Updated: 2018-3-19</p>
</div>

<footer class="footer menus">
  <nav>
    <ul class="footer-links">
      <li><a href="/peripheral_brain/home.html">Home</a></li>
      <li><a href="/peripheral_brain/index.html">Disclaimer</a></li>
    </ul>
    <!-- <a href="/peripheral_brain/home.html"><img src="/peripheral_brain/images/logo_1000x1000.png" alt="Logo"> -->
  </nav>
</footer>


</body>
</html>
